| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 01/17/2002 | WO2002004429A1 Pyrimidine derivatives |
| 01/17/2002 | WO2002004427A1 Phenylpyridazine derivatives and drugs containing the same |
| 01/17/2002 | WO2002004426A1 Squaric acid derivatives containing a bicyclic heteroaromatic ring as integrin antagonists |
| 01/17/2002 | WO2002004425A2 Viral polymerase inhibitors |
| 01/17/2002 | WO2002004424A1 Pyrazole derivatives |
| 01/17/2002 | WO2002004423A1 Thrombin inhibitors comprising an aminoisoquinoline group |
| 01/17/2002 | WO2002004421A2 Pyridoxine and pyridoxal analogues: cardiovascular therapeutics |
| 01/17/2002 | WO2002004420A1 Piperidine coumpounds for use as ccr-3 inhibitors |
| 01/17/2002 | WO2002004416A2 Lactam metalloprotease inhibitors |
| 01/17/2002 | WO2002003991A2 Use of substituted indole compounds for increasing nitric oxide synthase activity |
| 01/17/2002 | WO2001068186A3 Use of cyanoquinolines for treating or inhibiting colonic polyps |
| 01/17/2002 | WO2001064200A3 Use of pdgf receptor tyrosine kinase inhibitors for the treatment of diabetic nephropathy |
| 01/17/2002 | WO2001062726A3 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses |
| 01/17/2002 | WO2001060826A3 SUCCINOYLAMINO CARBOCYCLES AND HETEROCYCLES AS INHIBITORS OF Aβ PROTEIN PRODUCTION |
| 01/17/2002 | WO2001039759A3 Sulfonic acid or sulfonylamino n-(heteroaralkyl)-azaheterocyclylamide compounds |
| 01/17/2002 | WO2001035948A3 Neurophilin ligands for treating ocular conditions |
| 01/17/2002 | WO2001019817A3 3-pyrrolidinyloxy-3'-pyridyl ether compounds useful for controlling chemical synaptic transmission |
| 01/17/2002 | WO2000071493A3 INHIBITORS OF FACTOR Xa |
| 01/17/2002 | US20020007085 Novel intermediates useful for the preparation of antihistaminic piperidine derivatives |
| 01/17/2002 | US20020007071 Treating disorders which include neuropeptide Y excess; antagonists, antagonism |
| 01/17/2002 | US20020007070 For inhibiting loss of blood platelets; inhibiting formation of blood platelet aggregates, fibrin, thrombus, and embolus; anticoagulants embedded in devices for blood collection, circulation, storage (catheters, dialysis machines); stents |
| 01/17/2002 | US20020007069 Reacting 5-methoxy-2-(((4-methoxy-3,5-dimethyl-2-pyridyl) methyl)thio)benzimidazole with 3-chloroperoxybenzoic acid in ethyl acetate; purifying by dissolving in methylamine and by precipitation via addition of hydrochloric acid; purity |
| 01/17/2002 | US20020007065 Cyclopentanone dihydropyridine compounds useful as potassium channel openers |
| 01/17/2002 | US20020006958 Substituted aminosalicylic acid amides with fungicidal effect and intermediate products for production thereof |
| 01/17/2002 | US20020006952 Kinase inhibitors; anticancer agents |
| 01/17/2002 | US20020006948 Central nervous system disorders; antiinflammatory agents |
| 01/17/2002 | US20020006946 Obesity, antidiabetic agents, cardiovascular disorders |
| 01/17/2002 | US20020006943 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis |
| 01/17/2002 | US20020006936 Anticancer agents; restenosis |
| 01/17/2002 | US20020006934 Phenyl-substituted imidazopyridines |
| 01/17/2002 | US20020006928 Phenyl-substituted indoles and indazoles |
| 01/17/2002 | US20020006927 Sulfonamide and carbamide derivatives of 6(5H)phenanthridinones and their uses |
| 01/17/2002 | US20020006924 Mixture of fipronil and antagonist of nicotenic acetylcholine receptors |
| 01/17/2002 | US20020006923 Thrombin inhibitors |
| 01/17/2002 | CA2415505A1 Lactam metalloprotease inhibitors |
| 01/17/2002 | CA2415492A1 Pyrazole derivatives |
| 01/17/2002 | CA2414188A1 Pyridoxine and pyridoxal analogues: cardiovascular therapeutics |
| 01/17/2002 | CA2414111A1 Use of substituted indole compounds for increasing nitric oxide synthase activity |
| 01/17/2002 | CA2413044A1 Composition and antiviral activity of substituted indoleoxoacetic piperazine derivatives |
| 01/17/2002 | CA2413042A1 Phenylpyridazine derivatives and drugs containing the same |
| 01/17/2002 | CA2413035A1 Thrombin inhibitors comprising an aminoisoquinoline group |
| 01/16/2002 | EP1171437A1 Pesticidal indazole or benzotriazole derivatives |
| 01/16/2002 | EP1171436A1 Process for the preparation of (pyridinylidene)-phthalides |
| 01/16/2002 | EP1171435A2 Pyrimidine-2-one derivatives as integrin receptor ligands |
| 01/16/2002 | EP1171434A1 Tetrahydroisoquinolinyl-indole derivatives for the treatment of depression |
| 01/16/2002 | EP1171424A1 Cyclo-alkyl substituted benzimidazoles and their use as parp inhibitors |
| 01/16/2002 | EP1171122A1 Pyrrolidine modulators of chemokine receptor activity |
| 01/16/2002 | EP0983237B1 Chemical process for the reduction of 1-substituted -3-hydroxymethyl-4- (4-fluorophenyl)tetrahydropyridines |
| 01/16/2002 | EP0742903B1 Piperidine analogs and conjugates of procainamide and napa |
| 01/16/2002 | EP0638075B1 Thiazole or imidazole derivatives as maillard reaction inhibitors |
| 01/16/2002 | CN1331693A 1,2-annelated quinoline derivatives |
| 01/16/2002 | CN1331691A Piperidines as CCR5 modulators |
| 01/16/2002 | CN1331689A 4-and 5-alkynyloxindoles and 4-and 5-alkenyloxindoles |
| 01/16/2002 | CN1331688A Aminopyrazole derivatives |
| 01/16/2002 | CN1331682A Substituted 2-phenylbenzimidazoles, prodn. thereof and their use |
| 01/16/2002 | CN1331680A N-aryl (thio) anthranilic acid amide derivatives, their prepn. and their use as VEGF receptor tyrosine kinase inhibitors |
| 01/16/2002 | CN1331679A 3-azabicyclo [3.1.0] hexane derivatives as opiate receptors ligands |
| 01/16/2002 | CN1331591A Piperidines as CCR5 modulators |
| 01/15/2002 | US6339158 Process for the preparation of chiral nicotinic, quinolinic or benzoic acid imidazolinone herbicides |
| 01/15/2002 | US6339099 Guanidine mimics as factor Xa inhibitors |
| 01/15/2002 | US6339094 2-acylaminopropanamines as tachykinin receptor antagonists |
| 01/15/2002 | US6339093 For therapy of neurodegeneration; used as nmda(n-methyl-d-aspartate)-receptor subtype selective blockers |
| 01/15/2002 | US6339090 For therapy of benign prostatic hyperplasia |
| 01/15/2002 | US6339089 Antihypoxic agents; chronic obstructive pulmonary disease; vasoconstriction; reduces blood partial pressure of carbon dioxide; respiratory disorders; under oxygen inhalation treatment |
| 01/15/2002 | US6339087 For therapy of inflammatory or allergic diseases are selected from asthma, allergic rhinitis, hypersensitivity lung diseases, hypersensitivity pneumonitis, eosinophilic pneumonias, inflammatory bowel diseases, psoriasis, dermatitis |
| 01/15/2002 | US6339082 Tricyclic compounds, preparation method and said method intermediates, application as medicines and pharmaceutical compositions containing same |
| 01/10/2002 | WO2002002744A2 Dna encoding a human melanin concentrating hormone receptor (mch1) and uses thereof |
| 01/10/2002 | WO2002002554A1 Sulfonyl-pyrrolidine derivatives useful for the treatment of neurological disorders |
| 01/10/2002 | WO2002002551A1 4-heteroaryl-3-heteroarylidenyl-2-indolinones and their use as protein kinase inhibitors |
| 01/10/2002 | WO2002002550A1 Novel pyrazinone derivatives |
| 01/10/2002 | WO2002002549A1 Tetrahydropyridino or piperidino heterocyclic derivatives |
| 01/10/2002 | WO2002002539A1 Aryl phenylheterocyclyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immune-suppressive agents |
| 01/10/2002 | WO2002002534A1 Quinazolines with therapeutic use |
| 01/10/2002 | WO2002002533A1 Propane-1,3-dione derivatives |
| 01/10/2002 | WO2002002531A1 Nonpeptide substituted spirobenzoazepines as vasopressin antagonists |
| 01/10/2002 | WO2002002525A2 N-ureidoheterocycloaklyl-piperidines as modulators of chemokine receptor activity |
| 01/10/2002 | WO2002002524A1 Pyrrole derivatives for treating aids |
| 01/10/2002 | WO2002002522A1 Aryl phenycyclopropyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immune-suppressive agents |
| 01/10/2002 | WO2002002521A2 Aroyl aminoacyl pyrrole compounds and their pharmaceutical use |
| 01/10/2002 | WO2002002519A2 THROMBIN OR FACTOR Xa INHIBITORS |
| 01/10/2002 | WO2002002085A2 Rapidly-decomposing administrable form for releasing active ingredients in the oral cavity or in bodily cavities |
| 01/10/2002 | WO2001056993A3 Pyrazole compositions useful as inhibitors of erk |
| 01/10/2002 | WO2001052855A3 Drug combination for the treatment of depression and related disorders comprising mirtazapine and gepirone |
| 01/10/2002 | WO2001000615A8 Respiratory syncytial virus replication inhibitors |
| 01/10/2002 | US20020004600 Process for the preparation of substituted pyrimidines |
| 01/10/2002 | US20020004514 Anticancer compound and enantiomer separation method useful for synthesizing said compound |
| 01/10/2002 | US20020004513 Azacyclic compounds |
| 01/10/2002 | US20020004507 Anticaogulants |
| 01/10/2002 | US20020004503 Viricides |
| 01/10/2002 | US20020004501 Therapy for muscular disorders, urogenital disorders, gastrointestinal disorders, respiratory system disorders |
| 01/10/2002 | US20020004494 Muscular disorders, gastrointestinal disorders, respiratory system disorders |
| 01/10/2002 | US20020004198 Detecting viricides; mix polypeptide samples, incubate with modulator of protein activity, monitor sample viricidal activity |
| 01/10/2002 | US20020004032 Macrocyclic chelants for metallopharmaceuticals |
| 01/10/2002 | DE10030780A1 Kristallisationsmodifikation auf der Basis von Chinophthalonderivaten Crystallization modification on the basis of Chinophthalonderivaten |
| 01/10/2002 | CA2414468A1 4-heteroaryl-3-heteroarylidenyl-2-indolinones and their use as protein kinase inhibitors |
| 01/10/2002 | CA2414464A1 Aryl phenycyclopropyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immune-suppressive agents |
| 01/10/2002 | CA2414461A1 Aryl phenylheterocyclyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immune-suppressive agents |
| 01/10/2002 | CA2413245A1 N-ureidoheterocycloaklyl-piperidines as modulators of chemokine receptor activity |
| 01/10/2002 | CA2413243A1 Sulfonyl-pyrrolidine derivatives useful for the treatment of neurological disorders |
| 01/10/2002 | CA2413241A1 Thrombin or factor xa inhibitors |